Edition:
India

Pfizer Ltd (PFIZ.NS)

PFIZ.NS on National Stock Exchange of India

2,598.60INR
3:29pm IST
Change (% chg)

Rs2.25 (+0.09%)
Prev Close
Rs2,596.35
Open
Rs2,596.35
Day's High
Rs2,649.00
Day's Low
Rs2,590.00
Volume
21,506
Avg. Vol
23,331
52-wk High
Rs2,675.00
52-wk Low
Rs1,681.00

Chart for

About

Pfizer Limited is an India-based pharmaceutical company. The Company has a portfolio of approximately 140 products across over 15 therapeutic areas. The Company is engaged in manufacturing, marketing, trading and exporting pharmaceutical products. The Company offers a range of products for Anti-Allergic, Anti-Diabetic,... (more)

Overall

Beta: 0.04
Market Cap(Mil.): Rs81,362.34
Shares Outstanding(Mil.): 45.75
Dividend: 15.00
Yield (%): 0.84

Financials

  PFIZ.NS Industry Sector
P/E (TTM): 25.92 30.95 32.74
EPS (TTM): 68.62 -- --
ROI: -- 14.84 14.38
ROE: -- 16.34 16.08

BRIEF-India's Pfizer March Qtr Profit Rises

* MARCH QUARTER NET PROFIT 1.05 BILLION RUPEES VERSUS PROFIT OF 680.4 MILLION RUPEES YEAR AGO

07 May 2018

BRIEF-Pfizer Ltd Says Pfizer Inc Has Not Yet Made Decision w.r.t Strategic Alternatives For Global Consumer Healthcare Business​

* ‍PFIZER INC. TOLD CO'S BOARD THAT NO DECISION HAS YET BEEN MADE WITH RESPECT TO ANY STRATEGIC ALTERNATIVES FOR GLOBAL CONSUMER HEALTHCARE BUSINESS​

01 Mar 2018

BRIEF-Pfizer Says Ravi Prakash Bhagavathula Resigned As CFO

* SAYS RAVI PRAKASH BHAGAVATHULA RESIGNED AS CFO Source text - http://bit.ly/2CxVrV6 Further company coverage:

19 Feb 2018

BRIEF-India's Pfizer Dec-Qtr Profit Rises

* DEC QUARTER NET PROFIT 872.4 MILLION RUPEES VERSUS PROFIT OF 623.7 MILLION RUPEES YEAR AGO

24 Jan 2018

Earnings vs. Estimates